Clonal selection of metastasis within the life history of a tumor

Cancer Research

Volumn 67, Issue 24, 2007, Pages 11471-11475

  Talmadge, James E ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TRANSFORMATION; CLONAL VARIATION; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; LIFE HISTORY; METASTASIS; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR CELL; TUMOR GROWTH;

HUMANS; MODELS, GENETIC; NEOPLASM METASTASIS; NEOPLASMS;

EID: 37549003179     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2496     Document Type: Review

References (36)

1. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-5.
2. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
3. Talmadge JE, Fidler IJ. Cancer metastasis is selective or random depending on the parent tumour population. Nature 1982;297:593-4.
4. Talmadge JE, Wolman SR, Fidler IJ. Evidence for the clonal origin of spontaneous metastases. Science 1982;217:361-3.
5. Talmadge JE, Benedict K, Madsen J, Fidler IJ. Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases. Cancer Res 1984;44:3801-5.
6. Pathak S. Cytogenetic abnormalities in cancer: with special emphasis on tumor heterogeneity. Cancer Metastasis Rev 1990;8:299-318.
7. Wolman SR, McMorrow LE, Fidler IJ, Talmadge JE. Development and progression of karyotypic variability in melanoma K1735 following X-irradiation. Cancer Res 1985;45:1839-44.
8. Talmadge JE, Fidler IJ. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J Natl Cancer Inst 1982;69:975-80.
9. Cifone MA, Fidler IJ. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci U S A 1981;78:6949-52.
10. McMorrow LE, Wolman SR, Bornstein S, Talmadge JE. Irradiation-induced marker chromosomes in a metastasizing murine tumor. Cancer Res 1988;48:999-1003.
11. Kuukasjarvi T, Karhu R, Tanner M, et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997;57:1597-604.
12. Gancberg D, Di LA, Cardoso F, et al. Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. Ann Oncol 2002;13:1036-43.
13. Suzuki M, Tarin D. Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications. Molecular Oncology 2007;1:172-80.
14. Urquidi V, Sloan D, Kawai K, et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin Cancer Res 2002;8:61-74.
15. Montel V, Mose ES, Tarin D. Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. Int J Cancer 2006;119:251-63.
16. Gray JW. Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell 2003;4:4-6.
17. Schmidt-Kittler O, Ragg T, Daskalakis A, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A 2003;100:7737-42.
18. Bernards R, Weinberg RA. A progression puzzle. Nature 2002;418:823.
19. Weigelt B, Glas AM, Wessels LF, et al. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci U S A 2003;100:15901-5.
20. Michiels S, Koscielny S, Hill C. Interpretation of microarray data in cancer. Br J Cancer 2007;96:1155-8.
21. Fidler IJ, Kripke ML. Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat Genet 2003;34:23.
22. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-49.
23. Welch DR. Microarrays bring new insights into understanding of breast cancer metastasis to bone. Breast Cancer Res 2004;6:61-4.
24. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
25. Abal M, Fsihi H, Bras-Goncalves R, et al. Heterogeneous metastasis efficiency of isogenic orthotopic colon cancer xenografts reveals distinctive gene expression profiles. Tumour Biol 2007;28:139-50.
26. Hill RP, Chambers AF, Ling V, Harris JF. Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. Science 1984;224:998-1001.
27. Shekhar MP, Santner S, Carolin KA, Tait L. Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity. Am J Pathol 2007;170:1546-60.
28. Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005;65:5996-6000.
29. Kerbel RS, Waghorne C, Korczak B, Lagarde A, Breitman ML. Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications. Cancer Surv 1988;7:597-629.
30. Li F, Tiede B, Massague J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 2007;17:3-14.
31. von FD, Weber E, Hoeffken W, et al. Growth rate of 147 mammary carcinomas. Cancer 1980;45:2198-207.
32. Arnerlov C, Emdin SO, Lundgren B, et al. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population. Cancer 1992;70:1928-34.
33. Shackney SE, McCormack GW, Cuchural GJ, Jr. Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review. Ann Intern Med 1978;89:107-21.
34. Fidler IJ, Balch CM. The biology of cancer metastasis and implications for therapy. Curr Probl Surg 1987;24:129-209.
35. Masramon L, Vendrell E, Tarafa G, et al. Genetic instability and divergence of clonal populations in colon cancer cells in vitro. J Cell Sci 2006;119:1477-82.
36. Fidler IJ, Hart IR. Biological and experimental consequences of the zonal composition of solid tumors. Cancer Res 1981;41:3266-7.